Vivek Jain - 28 Dec 2021 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Chairman and CEO, Director
Signature: By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
Issuer symbol: ICUI
Transactions as of: 28 Dec 2021
Net transactions value: -$2,174,533
Form type: 4
Filing time: 30 Dec 2021, 15:59:06 UTC
Previous filing: 05 Nov 2021
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$9,642	+164	+1.3%	$58.79	12,943	28 Dec 2021	Direct	F1
transaction	ICUI	Common Stock	Sale	$39,360	-164	-1.3%	$240.00	12,779	28 Dec 2021	Direct	F1, F2
transaction	ICUI	Common Stock	Options Exercise	$627,701	+10,677	+84%	$58.79	23,456	29 Dec 2021	Direct	F1
transaction	ICUI	Common Stock	Sale	$2,562,493	-10,677	-46%	$240.00	12,779	29 Dec 2021	Direct	F1, F3
transaction	ICUI	Common Stock	Options Exercise	$68,138	+1,159	+9.1%	$58.79	13,938	30 Dec 2021	Direct	F1
transaction	ICUI	Common Stock	Sale	$278,160	-1,159	-8.3%	$240.00	12,779	30 Dec 2021	Direct	F1, F2
holding	ICUI	Common Stock						60,000	28 Dec 2021	by Trust	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-164	-0.06%	$0.000000	254,202	28 Dec 2021	Common Stock	164	$58.79	Direct	F1
transaction	ICUI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-10,677	-4.2%	$0.000000	243,525	29 Dec 2021	Common Stock	10,677	$58.79	Direct	F1
transaction	ICUI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,159	-0.48%	$0.000000	242,366	30 Dec 2021	Common Stock	1,159	$58.79	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021.
F2	All shares sold were sold at the exact price disclosed.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.07, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4	This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.